The Global Genes RARE Corporate Alliance is a coalition of more than 80 rare disease industry stakeholders that are committed to collaboration between industry and patient communities to improve and expedite access to effective therapies for all rare patients.
Membership is open to pharmaceutical and biotech companies, industry and academia that want to support patient education, community building and improved access to approved rare disease treatments.
Contact us to learn more about becoming a RARE Corporate Alliance member.
The organizations and the alliances Global Genes partners with have a patient focus, community-centered approach and like-minded vision for the future.
The RARE Corporate Alliance third quarter meeting will be held Wednesday, September 18 from 12:30 p.m. – 4:30 p.m. in conjunction with the RARE Patient Advocacy Summit.